Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia

This retrospective study compared efficacy and safety of fludarabine combined with intermediate-dose cytarabine (FA regimen) versus high-dose cytarabine (HiDAC regimen) as consolidation therapy in acute myeloid leukemia (AML) patients who achieved complete remission. Disease-free survival (DFS) and...

詳細記述

保存先:
書誌詳細
出版年:Medicine (Baltimore)
主要な著者: Zhang, Wenjun, Ding, Yi, Wu, Hao, Chen, Yuhua, Lu, Huina, Chen, Chunying, Fu, Jianfei, Wang, Weiguang, Liang, Aibin, Zou, Shanhua
フォーマット: Artigo
言語:Inglês
出版事項: Wolters Kluwer Health 2014
主題:
4800
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602804/
https://ncbi.nlm.nih.gov/pubmed/25501050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000134
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料